Skip to menu Skip to content Skip to footer
Dr Dave Coman
Dr

Dave Coman

Email: 

Overview

Background

David is a Consultant Paediatrician, Metabolic Physician, Clinical Geneticist and clinician researcher. His area of expertise is the diagnosis and management of children with rare diseases. David is involved in multiple ongoing research projects aimed at novel disease discovery, improved diagnostic testing and treatments for children with inherited genetic disorders. He is director of a national clinic for Ataxia Telangiectasia brashat.org.au and has recently been awarded a $2.5 million NHMRC research grant for a phase 2/3 trial for treatment of this disorder.

Availability

Dr Dave Coman is:
Available for supervision

Qualifications

  • Australian Health Practitioner Regulation Agency, Australian Health Practitioner Regulation Agency
  • Australian Medical Association, Australian Medical Association
  • Human Genetics Society of Australasia, Human Genetics Society of Australasia
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • Society for the Study of Inborn Errors of Metabolism, Society for the Study of Inborn Errors of Metabolism

Research impacts

David has close relationships with research colleagues both in Australia and internationally. He has multiple ongoing research projects investigating novel disease identification, the genetics of paediatric speech disorders and the development of new therapeutic possibilities for children and adults with rare diseases.

Works

Search Professor Dave Coman’s works on UQ eSpace

140 works between 2005 and 2026

1 - 20 of 140 works

2026

Journal Article

From genotype to outcome: Zygosity-specific insights in 63 cases of<i> CLPB</i>-related mitochondrial disease

Heath, Oliver, Del Cano-Ochoa, Francisco, Baris, Safa, Carrozzo, Rosalba, Coman, David, Distelmaier, Felix, Ellaway, Carolyn, Feichtinger, Rene G., Finocchi, Andrea, Guerrero-Castillo, Sergio, Halligan, Rebecca, Hannibal, Iris, Kritzer, Amy, Lichter-Konecki, Uta, Merkevicius, Kajus, Panis, Bianca, Pitceathly, Robert D. S., Pizzamiglio, Chiara, Iwanicka-Pronicka, Katarzyna, Rahman, Shamima, Seltzer, Laurie, Siepermann, Meinolf, Tal, Galit, Wevers, Ron A., Zietkiewicz, Szymon, Ramon-Maiques, Santiago, Mayr, Johannes A. and Wortmann, Saskia B. (2026). From genotype to outcome: Zygosity-specific insights in 63 cases of CLPB-related mitochondrial disease. Molecular Genetics and Metabolism, 147 (4) 109752. doi: 10.1016/j.ymgme.2026.109752

From genotype to outcome: Zygosity-specific insights in 63 cases of<i> CLPB</i>-related mitochondrial disease

2026

Journal Article

Abnormal Newborn Screening Resembling Carnitine Palmitoyltransferase 1a Deficiency in Three Patients With COASY Protein Associated Neurodegeneration

Lynch, Matthew, Manoy, Sophie, Murray, Claire, Wallace, Geoff, Pereira, Nolette, Price, Ricky, Inwood, Anita, McGill, Jim and Coman, David (2026). Abnormal Newborn Screening Resembling Carnitine Palmitoyltransferase 1a Deficiency in Three Patients With COASY Protein Associated Neurodegeneration. JIMD Reports, 67 (2) e70066, 2. doi: 10.1002/jmd2.70066

Abnormal Newborn Screening Resembling Carnitine Palmitoyltransferase 1a Deficiency in Three Patients With COASY Protein Associated Neurodegeneration

2026

Journal Article

Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

Manoy, Sophie, Minto, Tahlee, Demetriou, Kalliope, Lynch, Matthew, Selvanathan, Arthavan, Jardine, Luke, Lipke, Michelle, Bursle, Carolyn, Inwood, Anita, McGill, Jim and Coman, David (2026). Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency. JIMD Reports, 67 (2) e70076. doi: 10.1002/jmd2.70076

Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

2026

Journal Article

PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia

Masson, Aymeric, Paccaud, Julien, Orefice, Martina, Colin, Estelle, Mäkitie, Outi, Cormier-Daire, Valérie, Relator, Raissa, Ghosh, Sourav, Strub, Jean-Marc, Schaeffer-Reiss, Christine, Marcelis, Carlo, Koolen, David A., Pfundt, Rolph, de Boer, Elke, Vissers, Lisenka E.L.M., Gardeitchik, Thatjana, Aarts, Lonneke A.M., Rinne, Tuula, Terhal, Paulien A., Verbeek, Nienke E., Zuurbier, Linda C., Plomp, Astrid S., Wessels, Marja W., de Man, Stella A., Bouman, Arjan, Bird, Lynne M., Saadeh-Haddad, Reem, Guillen Sacoto, Maria J., Person, Richard ... Vitobello, Antonio (2026). PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia. Journal of Clinical Investigation, 136 (1) e182100. doi: 10.1172/JCI187998

PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia

2026

Journal Article

The Clinical Spectrum and Neurodevelopmental Pathogenesis of KPTN-Related Disorder in a Mouse Model

Rawlins, Lettie E., Iffland, Philip H., Page, John, Flessner, Rebecca Z., Elziny, Soad M., Sbornova, Irina, Babus, Janice K., Bruckmeier, Sophie R., Parikh, Ria, Verhoeven, Merel, Fasham, James, Leslie, Joseph S., Caswell, Richard, Ubeyratna, Nishanka, Wenger, Olivia, Scott, Ethan M., Schreiber, John, Syrbe, Steffen, Klabunde-Cherwon, Annick, Owens, Martina, Crosby, Andrew H., Baple, Emma L., Crino, Peter B., Seeley, Andrea, Rocha, Heather, Rudnick, Sabine, Schaatz, Ulrich, Haack, Tobias, Schwaibold, Eva ... Syrbe, Steffen (2026). The Clinical Spectrum and Neurodevelopmental Pathogenesis of KPTN-Related Disorder in a Mouse Model. Annals of Neurology ana.78159. doi: 10.1002/ana.78159

The Clinical Spectrum and Neurodevelopmental Pathogenesis of KPTN-Related Disorder in a Mouse Model

2026

Journal Article

SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum

Lee, Eunhye, Sim, Seungmin, Choi, Hee-Jung, Liang, Eugene Y., Le, Carolyn, Bina, Roya, Cohen, Ryan, George, Elizabeth, Kim, Soo Yeon, Bhat, Gifty, Falsey, Erin, Sidlow, Richard, Clinard, Kristin, Ben-Shachar, Shay, England, Eleina, Menendez, Beatriz, Herman, Isabella, Nielsen, Shelly, Punetha, Jaya, Bhola, Priya, Hamm, J. Austin, Keeney, Megan A., Sitzman, Nike, Berger, Sara, Mehta, Lakshmi, Conn, Alison J., Downie, Lilian, Ashfaq, Myla, Northrup, Hope ... Argilli, Emanuela (2026). SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum. Human Molecular Genetics, 35 (4) ddag003. doi: 10.1093/hmg/ddag003

SUPT16H-associated neurodevelopmental disorder and neurocristopathy: genetic and phenotypic spectrum

2026

Journal Article

Childhood motor speech disorders: who to prioritise for genetic testing

Van Niel, Halianna, Lauretta, Mariana, Baker, Emma, O’Donnell, Lorraine, Boulton, Charlotte, Brenchley, Celia, Coman, David, Michellis, Evyenia, Goel, Himanshu, Thompson, Geoff, Webster, Richard, Paxton, Georgia, Stark, Zornitza, Scheffer, Ingrid E., Hildebrand, Michael S., Amor, David J. and Morgan, Angela T. (2026). Childhood motor speech disorders: who to prioritise for genetic testing. European Journal of Human Genetics PMID 9302235. doi: 10.1038/s41431-025-01993-9

Childhood motor speech disorders: who to prioritise for genetic testing

2026

Journal Article

Holocarboxylase synthetase deficiency: a second case report with neonatal cholestatic liver disease

Manoy, Sophie, Murray, Claire, Lynch, Matthew, Minto, Tahlee, Choo, Kelvin, Bursle, Carolyn, Lipke, Michelle, McGill, Jim, Inwood, Anita and Coman, David (2026). Holocarboxylase synthetase deficiency: a second case report with neonatal cholestatic liver disease. Journal of Inherited Metabolic Disease Reports, 67 (1) e70051. doi: 10.1002/jmd2.70051

Holocarboxylase synthetase deficiency: a second case report with neonatal cholestatic liver disease

2025

Journal Article

Lets talk about ataxia-telangiectasia: meeting report of the AT clinical research conference June 2025

Coman, David, Jeggo, Penny and Lavin, Martin (2025). Lets talk about ataxia-telangiectasia: meeting report of the AT clinical research conference June 2025. DNA Repair, 155 103907, 1-7. doi: 10.1016/j.dnarep.2025.103907

Lets talk about ataxia-telangiectasia: meeting report of the AT clinical research conference June 2025

2025

Conference Publication

The Australian Genomic Health Alliance (AGHA) Mitochondrial Flagship:delivering mitochondrial disease diagnoses nationally

Rius, Rocio, Compton, Alison, Baker, Naomi, Balasubramaniam, Shanti, Bhattacharya, Kaustuv, Bratkovic, Drago, Coman, David, Delatycki, Martin, Ellaway, Carolyn, Fahey, Michael, Fletcher, Janice, Frazier, Ann, Ghaoui, Roula, Goranitis, Ilias, Hock, Daniella, Kava, Maina, Lake, Nicole, Lamont, Phillipa, Lee, Joy, McGill, Jim, Panetta, Julie, Phillips, Liza, Ryan, Michael, Smith, Nicholas, Stroud, David, Tchan, Michel, Wallis, Mathew, Welch, AnneMarie, Wools, Christine ... Christodoulou, John (2025). The Australian Genomic Health Alliance (AGHA) Mitochondrial Flagship:delivering mitochondrial disease diagnoses nationally. 58th Conference of the European-Society-of-Human-Genetics (ESHG), Milan Italy, May 24-27, 2025. LONDON: SPRINGERNATURE.

The Australian Genomic Health Alliance (AGHA) Mitochondrial Flagship:delivering mitochondrial disease diagnoses nationally

2025

Journal Article

PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia

Masson, Aymeric, Paccaud, Julien, Orefice, Martina, Colin, Estelle, Mäkitie, Outi, Cormier-Daire, Valérie, Relator, Raissa, Ghosh, Sourav, Strub, Jean-Marc, Schaeffer-Reiss, Christine, Marcelis, Carlo, Koolen, David A., Pfundt, Rolph, de Boer, Elke, Vissers, Lisenka E.L.M., Gardeitchik, Thatjana, Aarts, Lonneke A.M., Rinne, Tuula, Terhal, Paulien A., Verbeek, Nienke E., Zuurbier, Linda C., Plomp, Astrid S., Wessels, Marja W., de Man, Stella A., Bouman, Arjan, Bird, Lynne M., Saadeh-Haddad, Reem, Guillen Sacoto, Maria J., Person, Richard ... Vitobello, Antonio (2025). PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia. Journal of Clinical Investigation, 135 (22) e182100, 1-18. doi: 10.1172/jci182100

PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia

2025

Journal Article

Massively parallel sequencing: Successes, limitations and the future for inborn errors of metabolism

Manoy, Sophie, McGrath, Pauline, Smith, Sally, Swan, Lauren, Spicer, Janette, Atthow, Catherine, Somerville, Jesse, Elliott, Aoife, O'Neill, Sara, Roberts, Rhiannon, Allen, Laura, Ebzery, Camron, Boon, Melanie, Bursle, Carolyn, Lipke, Michelle, Lynch, Matthew, Inwood, Anita and Coman, David (2025). Massively parallel sequencing: Successes, limitations and the future for inborn errors of metabolism. Journal of Paediatrics and Child Health, 61 (9), 1523-1528. doi: 10.1111/jpc.70164

Massively parallel sequencing: Successes, limitations and the future for inborn errors of metabolism

2025

Conference Publication

Structural variants (SVs) underlying neurogenetic and neuromuscular diseases

Ravenscroft, G., Scriba, C., Folland, C., Bryen, S., Weisburd, B., Monahan, G., Rick, A., Rodrigues, M., Corbett, M., Gecz, J., Davis, M., Ashton, C., Coman, D., Yau, W., Roxburgh, R., Lamont, P. and Laing, N. (2025). Structural variants (SVs) underlying neurogenetic and neuromuscular diseases. 30th World Muscle Society Congress, Vienna, Austria, 7-11 October 2025. London, United Kingdom: Elsevier. doi: 10.1016/j.nmd.2025.105769

Structural variants (SVs) underlying neurogenetic and neuromuscular diseases

2025

Journal Article

Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis

Lynch, Matthew, Manoy, Sophie, Sly, Peter D., Wainwright, Claire E., Wolvetang, Ernst, Feenstra, John E., Dowling, Jason, Ware, Robert S., Patel, Maharshi S., Hermith-Ramirez, Diana, Vogel, Adam, Preece, Kahn, Zappala, Tania, Dai, Shuan, Webber, Ann, Yeo, Abrey, Subramanian, Goutham, Rao, Geetha, Ma, Cindy S., Jose, Sara, Gatei, Magtouf, Xin, Bowen, Sandona, Nicoletta, Lewindon, Peter, Sinclair, Katherine G., Nayler, Sam, Lavin, Martin F. and Coman, David J. (2025). Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis. eBioMedicine, 118 105840, 1-17. doi: 10.1016/j.ebiom.2025.105840

Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis

2025

Journal Article

Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases

Hock, Daniella H., Caruana, Nikeisha J., Semcesen, Liana N., Lake, Nicole J., Formosa, Luke E., Amarasekera, Sumudu S. C., Stait, Tegan, Tregoning, Simone, Frajman, Leah E., Bournazos, Adam M., Robinson, David R. L., Ball, Megan, Reljic, Boris, Ryder, Bryony, Wallis, Mathew J., Vasudevan, Anand, Beck, Cara, Peters, Heidi, Lee, Joy, Tan, Natalie B., Freckmann, Mary-Louise, Harris, Madeleine, Martin, Ellenore M., McGrath, Pauline, Atthow, Catherine, Elbaum, Yoni, MacArthur, Daniel G., Balasubramaniam, Shanti, Siira, Stefan J. ... Stroud, David A. (2025). Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases. Genome Medicine, 17 (1) 58. doi: 10.1186/s13073-025-01467-z

Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases

2025

Journal Article

Biomarkers in Ataxia-Telangiectasia: a systematic review

Tiet, M. Y., Guțu, B.-I., Springall-Jeggo, P., Coman, D., Willemsen, M., Van Os, N., Doria, M., Donath, H., Schubert, R., Dineen, R. A., Biagiotti, S., Prayle, A. P., Group, A. T. Biomarker Working, Hensiek, A. E. and Horvath, R. (2025). Biomarkers in Ataxia-Telangiectasia: a systematic review. Journal of Neurology, 272 (2) 110, 110-2. doi: 10.1007/s00415-024-12766-7

Biomarkers in Ataxia-Telangiectasia: a systematic review

2025

Journal Article

The Australian Genomics Mitochondrial Flagship: a national program delivering mitochondrial diagnoses

Rius, Rocio, Compton, Alison G., Baker, Naomi L., Balasubramaniam, Shanti, Best, Stephanie, Bhattacharya, Kaustuv, Boggs, Kirsten, Boughtwood, Tiffany, Braithwaite, Jeffrey, Bratkovic, Drago, Bray, Alessandra, Brion, Marie-Jo, Burke, Jo, Casauria, Sarah, Chong, Belinda, Coman, David, Cowie, Shannon, Cowley, Mark, de Silva, Michelle G., Delatycki, Martin B., Edwards, Samantha, Ellaway, Carolyn, Fahey, Michael C., Finlay, Keri, Fletcher, Janice, Frajman, Leah E., Frazier, Ann E., Gayevskiy, Velimir, Ghaoui, Roula ... Thorburn, David R. (2025). The Australian Genomics Mitochondrial Flagship: a national program delivering mitochondrial diagnoses. Genetics in Medicine, 27 (1) 101271, 1-12. doi: 10.1016/j.gim.2024.101271

The Australian Genomics Mitochondrial Flagship: a national program delivering mitochondrial diagnoses

2025

Journal Article

The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-Analysis

Michael, Toni J.F., Kirubakaran, Ranita, Parab, Tanay, Wang, Rui, Grosser, Mark, Vollenhoven, Beverley J., Smith, Vinayak, Stocker, Sophie L., Vollenhoven, Beverley, Agresta, Franca, Bi, Mian, Birru, Emanuel, Coman, David, Devereaux, Nicholas, Gardner, David, Grosser, Mark, Hatamosa, Grant, Horta, Fabrizzio, Lin, Hua, Listijono, David, Sacks, Gavin, Smith, Vinayak, Stern, Kate, Stocker, Sophie, Tipper, Steven, Venter, Deon and Wang, Rui (2025). The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-Analysis. Clinical Pharmacology and Therapeutics, 118 (4) cpt.70014, 790-802. doi: 10.1002/cpt.70014

The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-Analysis

2024

Journal Article

Urinary chloride excretion in critical illness and acute kidney injury: a paediatric hypothesis-generating cohort study post cardiopulmonary bypass surgery

Mattke, Adrian C., Johnson, Kerry E., Ariyawansa, Krishanti, Trnka, Peter, Venugopal, Prem S., Coman, David, Schibler, Andreas and Gibbons, Kristen (2024). Urinary chloride excretion in critical illness and acute kidney injury: a paediatric hypothesis-generating cohort study post cardiopulmonary bypass surgery. Anaesthesia and Intensive Care, 52 (6) 310057X241265119, 1-10. doi: 10.1177/0310057X241265119

Urinary chloride excretion in critical illness and acute kidney injury: a paediatric hypothesis-generating cohort study post cardiopulmonary bypass surgery

2024

Journal Article

RNA variant assessment using transactivation and transdifferentiation

Nicolas-Martinez, Emmylou C., Robinson, Olivia, Pflueger, Christian, Gardner, Alison, Corbett, Mark A., Ritchie, Tarin, Kroes, Thessa, van Eyk, Clare L., Scheffer, Ingrid E., Hildebrand, Michael S., Barnier, Jean-Vianney, Rousseau, Véronique, Genevieve, David, Haushalter, Virginie, Piton, Amélie, Denommé-Pichon, Anne-Sophie, Bruel, Ange-Line, Nambot, Sophie, Isidor, Bertrand, Grigg, John, Gonzalez, Tina, Ghedia, Sondhya, Marchant, Rhett G., Bournazos, Adam, Wong, Wui-Kwan, Webster, Richard I., Evesson, Frances J., Jones, Kristi J., Azmanov, Dimitar N. ... Cooper, Sandra T. (2024). RNA variant assessment using transactivation and transdifferentiation. American Journal of Human Genetics, 111 (8), 1673-1699. doi: 10.1016/j.ajhg.2024.06.018

RNA variant assessment using transactivation and transdifferentiation

Funding

Current funding

  • 2026 - 2029
    Therapeutic development targeting newly identified mechanism of Ataxia Telangiectasia disease
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Metabolic Medicine Research Clinical Trial in Ataxia-Telangiectasia
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2023 - 2028
    Introducing Mitochondrial Donation into Australia: The mitoHOPE (Healthy Outcomes Pilot and Evaluation) Program (MRFF EPCDRI grant led by Monash)
    Monash University
    Open grant
  • 2023 - 2028
    Translational Centre for Speech Disorders (NHMRC Centre of Research Excellence administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant

Past funding

  • 2021 - 2024
    Repairing catalase function in A-T patients using a CAT-SKL therapeutic
    National Stem Cell Foundation of Australia Matched Funding Program
    Open grant
  • 2020 - 2023
    A Phase 2A/2B placebo-controlled randomised clinical trial to test the ability of triheptanoin to protect primary airway epithelial cells obtained from patients with ataxia-telangiectasia against....
    BrAshA-T Ataxia-Telangiectasia Research Funding
    Open grant
  • 2020 - 2022
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    Wesley Medical Research Ltd
    Open grant
  • 2020 - 2025
    Ataxia-telangiectasia: treating mitochondrial dysfunction with a novel form of anaplerosis
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2011 - 2013
    Early prediction of intellectual and cognitive-linguistic outcomes in children with treated galactosaemia
    APEX Foundation for Research into Intellectual Disability Ltd (AFRID)
    Open grant

Supervision

Availability

Dr Dave Coman is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Dave Coman's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au